Ocubil - Bilberry fruit [Vaccinium myrtillus L] | VetSafeCare.Com

Cap.

Ocubil

Bilberry fruit [Vaccinium myrtillus L] — Square Pharmaceuticals Ltd.
160mg / capsule

Alternatives

3

Routes

PO

Presentations

1

Generic profile Browse alternatives View combinations

Presentations

Capsule · 160mg / capsule

1 capsule

৳20

Dose rules

No structured dose rules are linked to this brand yet.

Dose reference

Human

One 160 mg capsule should be taken 2-3 times daily or as per the instruction of a physician.

Clinical notes

Applications:

N/A

Indication Notes:
Bilberry fruit  is indicated in Retinopathy (hypertensive and diabetic), Night blindness, Cataracts, Macular degeneration, Retinitis pigmentosa and Hemorrhagic retinopathy.
Avoid In:

N/A

Contraindication Notes:
None known
Bilberry extract is used to treat Retinopathy, Cataracts, Macular degeneration, Retinitis pigmentosa, Hemorrhagic retinopathy. Bilberry anthocyanins regenerate rhodopsin are indicated in the treatment of poor night vision and cataracts. Bilberry is also used to treat microcirculatory disorders which include varicose veins, atherosclerosis, venous insufficiency.MECHANISM OF ACTION: Inhibits enzymatic cleavage of collagen by the enzymes secreted by leucocytes during Inflammation. By inhibiting retinal phosphoglucomutase and glucose-6-phosphatase it confers retinal protection. Reduces microvascular impairments due to ischemic reperfusion injury, with preservation of endothelium, attenuation of leukocyte adhesion and improvement of capillary perfusion. Produces dose dependent inhibition of platelet aggregation and clot retraction. Decreases basement membrane collagen hydrolysis by significantly reducing permeability of the blood-brain barrier and increases recovery rate of the BBB caused by permeability-increasing agents.
None known. Very high doses ( more than 170 mg anthocyanins daily for 30-60 days) may interact with warfarin or other antiplatelet drugs.
None known.
No known restriction.